Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause.

Archer DF, Pinkerton JV, Guico-Pabia CJ, Hwang E, Cheng RF; Study 3353 Investigators.

Menopause. 2013 Jan;20(1):47-56. doi: 10.1097/gme.0b013e3182775fe9.

PMID:
23266840
[PubMed - indexed for MEDLINE]
2.

Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study.

Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, Robinson JG, Rosal MC, Wenger NK, Wassertheil-Smoller S.

Arch Intern Med. 2009 Dec 14;169(22):2128-39. doi: 10.1001/archinternmed.2009.436.

PMID:
20008698
[PubMed - indexed for MEDLINE]
3.

Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.

Johansen OE, Qvigstad E.

Adv Ther. 2008 Jun;25(6):525-51. doi: 10.1007/s12325-008-0070-6. Review.

PMID:
18568306
[PubMed - indexed for MEDLINE]
4.

Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.

de Simone G, Romano C, De Caprio C, Contaldo F, Salanitri T, di Luzio Paparatti U, Pasanisi F.

Nutr Metab Cardiovasc Dis. 2005 Feb;15(1):24-30.

PMID:
15871847
[PubMed - indexed for MEDLINE]
5.

Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI).

Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, Robbins J, Aragaki A, Dunbar-Jacob J.

Arch Intern Med. 2004 Feb 9;164(3):289-98.

PMID:
14769624
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk